Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition melatonin and metformin to toremifene in the treatment of
locally advanced breast cancer. Third of patients will receive toremifene, other third will
receive combination of melatonin and toremifene and other patients will receive combination
of metformin and toremifene.
Phase:
Phase 2
Details
Lead Sponsor:
N.N. Petrov National Medical Research Center of Oncology Petrov Research Institute of Oncology